Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 6/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | ABAT | P80404 | 1/20 | 0.38 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL107343 | 1.00 | TAAR1 (0.45) | TAAR1SLC6A2ESR1ESR2IDO1 | |
| SCHEMBL106554 | 0.82 | ESR1 (0.42) | TAAR1SLC6A2ESR1ESR2IDO1 | |
| SCHEMBL106553 | 0.82 | ESR1 (0.42) | TAAR1SLC6A2ESR1ESR2IDO1 | |
| SCHEMBL106563 | 0.80 | ESR1 (0.48) | TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL106564 | 0.80 | ESR1 (0.48) | TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL448422 | 0.79 | ESR1 (0.55) | TAAR1SLC6A2ESR1ESR2IDO1 | |
| SCHEMBL448421 | 0.79 | ESR1 (0.55) | TAAR1SLC6A2ESR1ESR2IDO1 | |
| SCHEMBL107005 | 0.78 | MAOB (0.61) | TAAR1SLC6A2 | |
| SCHEMBL107006 | 0.78 | MAOB (0.61) | TAAR1SLC6A2 | |
| SCHEMBL107430 | 0.78 | TAAR1 (0.44) | TAAR1SLC6A2ESR1ESR2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2463374-A2 | Isolated alcohol dehydrogenase enzymes and uses thereof | Bio Architecture Lab, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| EP-3230463-B2 | RAPID PRETREATMENT | APALTA PATENTS OUE (EE) | 2025-07-16 | — | — | EP | disclosed |
| US-20240425893-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2024-12-26 | — | — | US | disclosed |
| US-12054761-B2 | Rapid pretreatment | Apalta Patents OÜ (EE) | 2024-08-06 | — | — | US | disclosed |
| US-11821047-B2 | High pressure zone formation for pretreatment | Apalta Patent OÜ (EE) | 2023-11-21 | — | — | US | disclosed |
| US-20230295678-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2023-09-21 | — | — | US | disclosed |
| EP-4098750-A1 | RAPID PRETREATMENT | Sweetwater Energy, Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| EP-3230463-B1 | RAPID PRETREATMENT | SWEETWATER ENERGY INC (US) | 2022-05-25 | — | — | EP | disclosed |
| US-11332723-B2 | Engineered microorganisms for production of commodity chemicals and cellular biomass | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-05-17 | — | — | US | disclosed |
| US-20100279354-A1 | ADAPTING MICROORGANISMS FOR AGRICULTURAL PRODUCTS | EVOLUGATE, LLC (US) | 2010-11-04 | — | — | US | disclosed |
| WO-2010124147-A1 | COMPOSITIONS AND METHODS FOR METHANE PRODUCTION | QTEROS, INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| WO-2010123932-A1 | COMPOSITIONS AND METHODS FOR FERMENTATION OF BIOMASS | QTEROS, INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| US-20100268000-A1 | Compositions and Methods for Fermentation of Biomass | QTEROS, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| WO-2010104896-A1 | PRODUCTION OF FERMENTIVE END PRODUCTS FROM CLOSTRIDIUM SP. | QTEROS, INC. (US) | 2010-09-16 | — | — | WO | disclosed |
| US-20100086981-A1 | COMPOSITIONS AND METHODS FOR IMPROVED SACCHARIFICATION OF BIOMASS | QTEROS, INC. (US) | 2010-04-08 | — | — | US | disclosed |
| US-20090203089-A1 | ISOLATED ALCOHOL DEHYDROGENASE ENZYMES AND USES THEREOF | BIO ARCHITECTURE LAB, INC. (US) | 2009-08-13 | — | — | US | disclosed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | disclosed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | TAAR1 1927/4885SLC6A2 4843/4885ESR1 3581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.